Pain Outcomes Comparing Yoga Versus Structured Exercise (POYSE) Trial (POYSE)
10. února 2020 aktualizováno: VA Office of Research and Development
The Pain Outcomes comparing Yoga versus Structured Exercise (POYSE) Trial is a 2-arm parallel group, randomized clinical trial to compare the effectiveness of a yoga-based intervention (YOGA) with that of a structured exercise program (SEP) for subjects with fibromyalgia.
The study aims are: 1) to compare the interventions' (YOGA vs. SEP) effects on overall fibromyalgia severity at 1 month (early response), 3 months (immediate post-intervention) and at 6 and 9 months (sustained effects); 2) to compare the interventions effects on specific fibromyalgia symptoms (pain, sleep, and fatigue), functional impairment, and related outcomes (quality of life, psychological symptoms); and 3) to compare the cost-effectiveness of the interventions.
Přehled studie
Detailní popis
This study sample will include 306 Veterans with fibromyalgia.
Patients will be randomized to one of two treatment arms.
The YOGA arm will involve a standardized 12-week, yoga-based intervention.
The yoga intervention will consist of three treatment components: 1) in-person group yoga taught by a certified yoga therapist; 2) a relaxation audio recording for home-use; and 3) a DVD recording to reinforce concepts taught during in-person yoga sessions.
Patients randomized to the structured exercise program (SEP) arm will participate in a 12-week exercise program delivered in a group/class format and supervised by a fitness instructor.
In addition, SEP patients will receive a DVD (for home use) describing the benefits of aerobic exercise for fibromyalgia, a one-on-one consultation session with the fitness instructor, an individualized exercise prescription, and supervised exercise sessions for 12 weeks.
Typ studie
Intervenční
Zápis (Aktuální)
256
Fáze
- Nelze použít
Kontakty a umístění
Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.
Studijní místa
-
-
Indiana
-
Indianapolis, Indiana, Spojené státy, 46202-2884
- Richard L. Roudebush VA Medical Center, Indianapolis, IN
-
-
Kritéria účasti
Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.
Kritéria způsobilosti
Věk způsobilý ke studiu
18 let a starší (Dospělý, Starší dospělý)
Přijímá zdravé dobrovolníky
Ne
Pohlaví způsobilá ke studiu
Všechno
Popis
Inclusion Criteria:
Veterans will be eligible if they have:
- Widespread Pain Index (WPI) greater than 7 and Symptom Severity Scale (SS) greater than 5 or WPI 3-6 and SS greater than 9.
- Symptoms have been present at a similar level for at least 3 months
- The subject does not have a disorder that would otherwise explain the pain
- Moderate pain severity (pain severity score greater than 5)
- No changes in fibromyalgia medications for last 4 weeks
- Access to a working telephone
Exclusion Criteria:
Exclusion criteria includes:
- Severe medical conditions in which exercise is contraindicated (such as significant cardiovascular disease, COPD or asthma needing home oxygen, stroke or TIA in last 6 months, cancer (other than skin cancer) and receiving treatment for it
- Active psychosis
- Hospitalized for psychiatric reasons within the last 6 months
- Active suicidal ideation
- Moderate to severe cognitive impairment
- Involvement in ongoing yoga classes or moderately intense exercise program in the last 3 months
Studijní plán
Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Yoga
A 12-week yoga intervention modified for Veterans with fibromyalgia.
Each weekly session will last approximately 75 minutes.
The standardized sequence of yoga poses will be introduced to participants and the instructor will tailor them to the participant's needs and abilities.
Deep breathing exercises will be taught and emphasized throughout every session.
Participants will be encouraged to exercise according to their limits, rather than rigid adherence to posture techniques.
The yoga intervention will be tailored to the individual.
It will include low intensity, low impact modified poses adapted with pathophysiologic changes of fibromyalgia in mind.
Participants will also be given a Playaway(c) device with guided relaxation exercise recorded on it and asked to listen to it three times a week to reinforce the in person yoga session content.
|
A 12-week yoga intervention modified for Veterans with fibromyalgia.
Each weekly session will last approximately 75 minutes.
The standardized sequence of yoga poses will be introduced to participants and the instructor will tailor them to the participant's needs and abilities.
Deep breathing exercises will be taught and emphasized throughout every session.
Participants will be encouraged to exercise according to their limits, rather than rigid adherence to posture techniques.
The yoga intervention will be tailored to the individual.
It will include low intensity, low impact modified poses adapted with pathophysiologic changes of fibromyalgia in mind.
Participants will also be given a Playaway(c) device with guided relaxation exercise recorded on it and asked to listen to it three times a week to reinforce the in person yoga session content.
|
|
Aktivní komparátor: Structured Exercise
A 12-week group exercise session consisting of a graded aerobic exercise program.
The program will start at low intensity with gradual increases in exercise intensity and duration.
Each weekly session will last 75 minutes.
The fitness instructor will teach participants to use a table-top ergometer at a sub-maximal level, determine baseline fitness, and develop an individualized exercise prescription.
The fitness instructor will provide educational tips on exercise and selection of physical activities.
Participants will be given a pedometer and heart rate monitor to track their exercise at home.
They will also be given an exercise DVD to use at home.
|
A 12-week group exercise session consisting of a graded aerobic exercise program.
The program will start at low intensity with gradual increases in exercise intensity and duration.
Each weekly session will last 75 minutes.
The fitness instructor will teach participants to use a table-top ergometer at a sub-maximal level, determine baseline fitness, and develop an individualized exercise prescription.
The fitness instructor will provide educational tips on exercise and selection of physical activities.
Participants will be given a pedometer and heart rate monitor to track their exercise at home.
They will also be given an exercise DVD to use at home.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Fibromyalgia Impact Questionnaire Revised (FIQR) Total Score
Časové okno: 3 month
|
This measure will be assessed at Baseline, 1, 3, 6 and 9 months.
The 3 month is the primary end point and the 6 and 9 month assessments are for sustained effect.
Min:0, Max: 90.
Higher Score = Worse Outcome.
|
3 month
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Fibromyalgia Impact Questionnaire-Revised Difficulty Subscale
Časové okno: 3 Month
|
This represents a subscale of the FIQr and measures patient perceived difficulty related to fibromyalgia.
Min:0, Max: 20.
Higher Score = Worse Outcome.
|
3 Month
|
|
Fibromyalgia Impact Questionnaire-Revised Impact Subscale
Časové okno: 3 Month
|
This is a subscale of the FIQr and measures the overall impact of fibromyalgia symptoms.
Min:0, Max: 100.
Higher Score = Worse Outcome.
|
3 Month
|
|
Fibromyalgia Impact Questionnaire Revised Symptoms Subscale
Časové okno: 3 Month
|
This subscale of the FIQr provides an overall fibromyalgia symptom score.
Min:0, Max: 100.
Higher Score = Worse Outcome
|
3 Month
|
|
Brief Pain Inventory (BPI) Severity Subscale
Časové okno: 3 month
|
is an 11-item, multidimensional pain measurement tool with demonstrated reliability in patients with arthritis as well as other pain conditions.
The BPI rates the intensity of pain as well as the interference of pain with mood, physical activity, work, social activity, relations with others, sleep, and enjoyment of life.Min:0, Max: 40.
Higher Score = Worse Outcome.
|
3 month
|
|
PHQ-9 for Depression
Časové okno: 3 Month
|
will be used to assess depression severity.
Several studies have validated the PHQ-9 as a diagnostic measure with excellent psychometric properties.
Internal consistency has consistently been shown to be high (Cronbach's alpha > 0.80) and test-retest assessment showed the PHQ-9 to be a responsive and reliable measure of depression treatment outcomes.
Min:0, Max: 27.
Higher Score = Worse Outcome.
|
3 Month
|
|
GAD-7 Anxiety Scale
Časové okno: 3 Month
|
This 7-item scale represent a measure of anxiety symptom severity and provides a score from 0 to 21 with higher scores representing more severe anxiety
|
3 Month
|
|
PTSD Checklist of Symptoms
Časové okno: 3 Month
|
This 17-item scale assess PTSD symptom severity and provides a severity score; with higher scores representing more severe PTSD.
Min: 0, Max: 85 with higher scores representing more severity.
|
3 Month
|
|
SF-12 Physical Score (Health-related Quality of Life)
Časové okno: 3 Month
|
The SF-12 is a well-validate measure of health-related quality of life; providing a physical and mental health component summary score.
Min:0, Max: 100.
Higher Score = Worse Outcome.
|
3 Month
|
|
SF-12 Mental Score (Health-related Quality of Life)
Časové okno: 3 Month
|
The SF-12 is a well-validate measure of health-related quality of life; providing a physical and mental health component summary score.
Min:0, Max: 100.
Higher Score = Worse Outcome.
|
3 Month
|
|
Multi-dimensional Fatigue Inventory
Časové okno: 3 Month
|
This scale assesses overall fatigue and has been well-validated and used in other fibromyalgia trials.
Min:0, Max: 100.
Higher Score = Worse Outcome.
|
3 Month
|
|
MOS Sleep Scale - Problems Index
Časové okno: 3 Month
|
This scale assesses different aspects of sleep quality and provides an overall index with higher scores representing more severe sleep problems.
Min:0, Max: 100.
Higher Score = Worse Outcome.
|
3 Month
|
|
Pain Catastrophizing Scale
Časové okno: 3 Month
|
This 13-item scale assesses pain catastrophizing which has been found to be a predictor of poor treatment response.
Min: 0. Max: 52.
Higher Score = Worse Outcome.
|
3 Month
|
|
Arthritis Self-efficacy Scale
Časové okno: 3 Month
|
This scale has been well-validated to assess self-efficacy or confidence in a person's ability to complete a task.
Min: 0, Max: 60.
Higher score represents improvement.
|
3 Month
|
Spolupracovníci a vyšetřovatelé
Zde najdete lidi a organizace zapojené do této studie.
Publikace a užitečné odkazy
Osoba odpovědná za zadávání informací o studiu tyto publikace poskytuje dobrovolně. Mohou se týkat čehokoli, co souvisí se studiem.
Termíny studijních záznamů
Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.
Hlavní termíny studia
Začátek studia (Aktuální)
1. srpna 2013
Primární dokončení (Aktuální)
2. července 2018
Dokončení studie (Aktuální)
31. prosince 2018
Termíny zápisu do studia
První předloženo
20. února 2013
První předloženo, které splnilo kritéria kontroly kvality
20. února 2013
První zveřejněno (Odhad)
22. února 2013
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
24. února 2020
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
10. února 2020
Naposledy ověřeno
1. února 2020
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- D1100-R
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Ne
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Ne
Studuje produkt zařízení regulovaný americkým úřadem FDA
Ne
produkt vyrobený a vyvážený z USA
Ne
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .